Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.004 Å; R factor = 0.066; wR factor = 0.178; data-to-parameter ratio = 13.7.
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For the biological activity of N-substituted benzamides and benzanilide derivatives, see Calderone et al. (2006) ; Beccalli et al. (2005) ; Yoo et al. (2005) ; Vega-Noverola et al. (1989) ; Olsson et al. (2002) ; Lindgren et al. (2001) ; Zhichkin et al. (2007) . For related structures see: Saeed et al. (2008) ; Chopra & Guru Row (2008) ; Donnelly et al. (2008) Experimental Crystal data 
Data collection
Stoe IPDSII two-circle diffractometer Absorption correction: multi-scan (MULABS; Spek, 2009; Blessing, 1995) T min = 0.928, T max = 0.936 9469 measured reflections 2193 independent reflections 1787 reflections with I > 2(I) R int = 0.074 Refinement R[F 2 > 2(F 2 )] = 0.066 wR(F 2 ) = 0.178 S = 1.04 2193 reflections 160 parameters H atoms treated by a mixture of independent and constrained refinement Á max = 0.51 e Å À3 Á min = À0.47 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement: X-AREA; data reduction: X-AREA; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: PLATON (Spek, 2009) ; software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: YA2096).
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Comment
The benzanilide core is present in compounds with such a wide range of biological activities that it has been called a privileged structure. N-Substituted benzamides are well known anticancer compounds and the mechanism of action for N-substituted benzamide-induced apoptosis has been studied, using declopramide as a lead compound (Olsson et al., 2002) . N-Substituted benzamides inhibit the activity of nuclear factor-B and nuclear factor of activated T cells activity while inducing activator protein 1 activity in T lymphocytes (Lindgren et al., 2001) . Various N-substituted benzamides exhibit potent antiemetic activity (Vega-Noverola et al., 1989) , while heterocyclic analogs of benzanilide derivatives are potassium channel activators (Calderone et al., 2006) . o-Aryloxylation of N-substituted benzamides induced by the copper(II)/trimethylamine N-oxide system has been studied. N-Alkylated 2-nitrobenzamides are intermediates in the synthesis of dibenzo[b,e][1,4]diazepines (Zhichkin et al., 2007) and N-Acyl-2-nitrobenzamides are precursors of 2,3-disubstitued 3H-quinazoline-4-ones (Beccalli et al., 2005) . A one-pot conversion of 2-nitro-n-arylbenzamides to 2,3-dihydro-1H-quinazoline-4-ones has also been reported (Yoo et al., 2005) . As part of our work on the structure of benzanilides and related compounds, we report here the structure of the title 4-chlorobenzamide derivative, I, Fig 1. The dihedral angle between the two aromatic rings is 11.29 (15) °. The crystal packing is stabilized by N-H···O hydrogen bonds linking the molecules to chains running along the c axis.
Experimental 4-Chlorobenzoyl chloride (5.4 mmol) in CHCl 3 was treated with 3-methylaniline (21.6 mmol) under a nitrogen atmosphere at reflux for 3 h. Upon cooling, the reaction mixture was diluted with CHCl 3 and washed consecutively with aq 1 M HCl and saturated aq NaHCO 3 . The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Crystallization of the residue from CHCl 3 afforded the title compound (81%) as colourless blocks. Anal. calcd.
for C 14 H 12 Cl NO 1: C 68. 44, H 4.92, N 5.70%; found: C 68.39, H 4.90, N 5 
.67%
Refinement H atoms were located in a difference map but those bonded to C were geometrically positioned and refined using a riding model with fixed individual displacement parameters [U(H) = 1.2 U eq (C) or U(H) = 1.5 U eq (C methyl )] and C-H(aromatic) = 0.95Å or C-H(methyl) = 0.98 Å, respectively. The H atom bonded to N was refined isotropically, N-H 0.88 (3) Å. 
